Gastrointestinal endoscopy · 2009
Intraluminal implantation of radioactive stents for treatment of primary carcinomas of the peripancreatic-head region: a pilot study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Yan, Lu Zheng, Zou Duo-wu, Jin Zhen-dong, Liu Feng, Li Shu-de, Zhan Xian-bao, Zhang Wen-jun, Wu Ren-pei, Yao Yin-zhen, Yang Li, Li Zhaoshen
Аннотация
BACKGROUND: Patients diagnosed with bile-duct, pancreatic-head, and ampullary carcinomas have a poor prognosis.
OBJECTIVE: This study evaluated the potential curative efficacy and safety of intraluminal brachytherapy by using radioactive stents for palliative treatment of these patients.
DESIGN AND SETTING: Patients with inoperable extrahepatic bile-duct (n = 2), pancreatic-head (n = 6), or ampullary (n = 3) carcinomas were treated by intraluminal implantation of radioactive stents designed according to a computerized treatment-planning system.
INTERVENTIONS: Both radioactive stents and commonly used self-expanding metallic or plastic stents were placed in the common bile duct (CBD) of the patients. For pancreatic carcinoma, the combination of radioactive CBD and pancreatic duct (PD) stents or only a radioactive PD stent was chosen according to the tumor position.
MAIN OUTCOME MEASUREMENTS: Survival, tumor status, and complications were assessed during the follow-up period.
RESULTS: A total of 16 radioactive stents were successively placed in all 11 patients. There were no life-threatening complications. The median survival was 150 days. After 2 months of the placement of radioactive stents, 8 patients (72.7%) had stable disease, whereas 3 patients (27.3%) showed progressive disease.
CONCLUSIONS: The combination of radioactive stents and metallic and/or plastic stents was technically feasible and tolerable in patients with advanced tumors around the pancreatic-head area.
OBJECTIVE: This study evaluated the potential curative efficacy and safety of intraluminal brachytherapy by using radioactive stents for palliative treatment of these patients.
DESIGN AND SETTING: Patients with inoperable extrahepatic bile-duct (n = 2), pancreatic-head (n = 6), or ampullary (n = 3) carcinomas were treated by intraluminal implantation of radioactive stents designed according to a computerized treatment-planning system.
INTERVENTIONS: Both radioactive stents and commonly used self-expanding metallic or plastic stents were placed in the common bile duct (CBD) of the patients. For pancreatic carcinoma, the combination of radioactive CBD and pancreatic duct (PD) stents or only a radioactive PD stent was chosen according to the tumor position.
MAIN OUTCOME MEASUREMENTS: Survival, tumor status, and complications were assessed during the follow-up period.
RESULTS: A total of 16 radioactive stents were successively placed in all 11 patients. There were no life-threatening complications. The median survival was 150 days. After 2 months of the placement of radioactive stents, 8 patients (72.7%) had stable disease, whereas 3 patients (27.3%) showed progressive disease.
CONCLUSIONS: The combination of radioactive stents and metallic and/or plastic stents was technically feasible and tolerable in patients with advanced tumors around the pancreatic-head area.
Предметные рубрики MeSH
AdultAgedAged, 80 and overAmpulla of VaterBrachytherapyCommon Bile Duct NeoplasmsDisease ProgressionEquipment DesignFeasibility StudiesFemaleFollow-Up StudiesHumansIodine RadioisotopesMaleMiddle AgedNeoplasm StagingPancreatic DuctsPancreatic NeoplasmsPilot ProjectsRadiometryRadiotherapy Planning, Computer-AssistedStentsSurvival AnalysisTherapy, Computer-AssistedTreatment Outcome